首页 › 基金 › ARS Investment Partners, LLC › BHVN
ARS Investment Partners, LLC 对 BHVN 的持仓历史
BIOHAVEN LTD · 医疗保健
ARS Investment Partners, LLC 在 Q3 2026 的 13F 申报中披露持有 BHVN(BIOHAVEN LTD)1,372,668 股,市值约 US$18.3M,约占其申报组合的 0.82%,在其申报持仓中市值排名第 34 位。 ARS Investment Partners, LLC 最近 13 个申报季度中有 13 个季度披露了 BHVN 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
ARS Investment Partners, LLC 对 BHVN 的持仓演变
ARS Investment Partners, LLC 于 Q3 2023 首次披露 BHVN 持仓:624,349 股(约 US$16.2M)。 该持仓在 Q3 2024 达到峰值 1,030,239 股,市值约 US$51.5M。 在 13 次申报中,ARS Investment Partners, LLC 7 次增持、1 次减持、4 次保持不变。 最近一期申报(Q3 2026)显示持股 1,372,668 股、市值约 US$18.3M。 持仓曾出现大幅变动:Q2 2024 增持约 48% (随后一个季度股价上涨 44%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 624.35K | $16.24M | 新进 |
| Q4 2023 | 633.96K | $27.13M | 增持 |
| Q1 2024 | 636.37K | $34.80M | 持有 |
| Q2 2024 | 940.51K | $32.65M | 增持 |
| Q3 2024 | 1.03M | $51.48M | 增持 |
| Q4 2024 | 1.04M | $38.87M | 增持 |
| Q1 2025 | 1.04M | $38.84M | 持有 |
| Q2 2025 | 1.19M | $16.76M | 增持 |
| Q3 2025 | 1.10M | $16.55M | 减持 |
| Q4 2025 | 1.24M | $14.00M | 增持 |
| Q1 2026 | 1.38M | $11.66M | 增持 |
| Q2 2026 | 1.37M | $20.45M | 持有 |
| Q3 2026 | 1.37M | $18.33M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BHVN 与 13F 数据
BHVN(BIOHAVEN LTD)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 BHVN,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BHVN 的基金
- MONTANOVA CAPITAL, LLC 10.29M 股 · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M 股 · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M 股 · $43.70M · Q2 2026
- Cormorant Asset Management, LP 2.61M 股 · $38.84M · Q2 2026
- Knoll Capital Management, LLC 2.35M 股 · $35.01M · Q2 2026
- TCG Crossover Management, LLC 1.78M 股 · $26.49M · Q2 2026
更多关于 ARS Investment Partners, LLC
常见问题
How long has ARS Investment Partners, LLC held BHVN?
ARS Investment Partners, LLC has disclosed BHVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ARS Investment Partners, LLC's current position in BHVN?
As of Q3 2026, ARS Investment Partners, LLC holds 1.37M shares of BHVN (BIOHAVEN LTD), valued at $18.33M, representing 0.82% of its reported portfolio and ranking #34.
Has ARS Investment Partners, LLC been buying or selling BHVN?
In the latest 13F filing (Q3 2026), ARS Investment Partners, LLC held unchanged its position in BHVN. The position peaked in Q3 2024 at 1.03M shares.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.